Company intelligence / Profile preview

MSD Global Health Innovation Fund

North Wales, Pennsylvania, United States

Ownership: Private
Development stage: Other

Overview

MSD Global Health Innovation Fund is a corporate growth-investment fund of MSD (Merck & Co.) that invests in digital health and data-science companies to optimize biopharmaceutical operations, access, and patient care; it does not run its own therapeutic clinical programs.[4][5][8][10]

Industry: Investors

Partnerships

Portfolio co-investments with various venture funds and investors, including Baseimmune’s Series A syndicate (Beast Ventures, Creator Fund, Hoxton Ventures, IQ Capital, Maki.vc).[10]

Beyond the preview

Go deeper on MSD Global Health Innovation Fund.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MSD Global Health Innovation Fund.

Explore the full profile